Anteris Technologies Global Corp.

AVR | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.18

+$0.03 (+0.37%)

Sep 22, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.37%

(1D)

Rating

Updated: Aug 26, 2026

14.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $794.87M

1D Range

8.17 8.32

52W Range

3.30 11.06

Valuation (TTM)

PE -2.95

PB 3.15

EV/EBITDA -5.35

Valuation (NTM)

Forward PE N/A

Forward PEG 0.38

Price Target $18

Cash Flow

FCF Yield -11.1%

SBC Adj. FCF Yield -11.7%

SBC Impact -5.7%

Margins

Gross Margin 37.0%

Operating Margin -4738.4%

FCF Margin -3927.8%

Growth (CAGR)

Revenue 3Y | 5Y 6.0% | -18.9%

Dil EPS 3Y | 5Y -21.5% | -39.5%

FCF 3Y | 5Y -28.5% | -35.8%

Returns

ROA -38.0%

ROE -77.7%

ROIC -41.6%

Financial Health

Net Cash

$254.06M

Current Ratio 14.20

Interest Coverage -2,042.96

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with ao...

Sector Healthcare

Industry Medical - Devices

Employees 174

IPO Date Dec 12, 2024

Website anteristech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$18

Upside

+120.05%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞